Emerging role of mRNA epitranscriptomic regulation in chemoresistant cancer cells

1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cancer persister cells remain a significant barrier to effective anti-cancer therapy. We found that melanoma persister cells undergo a reversible reprogramming of mRNA translation. A subset of mRNAs, harboring N6-methyladenosine in their 5ʹ-untranslated regions, is translationally up-regulated in an eIF4A-dependent manner. Targeting eIF4A prevents the emergence of resistant clones.

References Powered by Scopus

A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations

2025Citations
N/AReaders
Get full text

Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition

1163Citations
N/AReaders
Get full text

Dynamic transcriptomic m<sup>6</sup>A decoration: Writers, erasers, readers and functions in RNA metabolism

1124Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The elusive road towards effective cancer prevention and treatment

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Shen, S., & Sun, X. (2020, May 3). Emerging role of mRNA epitranscriptomic regulation in chemoresistant cancer cells. Molecular and Cellular Oncology. Taylor and Francis Ltd. https://doi.org/10.1080/23723556.2020.1728467

Readers' Seniority

Tooltip

Researcher 3

50%

Professor / Associate Prof. 2

33%

PhD / Post grad / Masters / Doc 1

17%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 4

57%

Medicine and Dentistry 1

14%

Pharmacology, Toxicology and Pharmaceut... 1

14%

Social Sciences 1

14%

Save time finding and organizing research with Mendeley

Sign up for free